Prospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Apr 14, 2015; 21(14): 4310-4322
Published online Apr 14, 2015. doi: 10.3748/wjg.v21.i14.4310
Table 5 Cumulative effects of unfavorable genotypes on overall survival of hepatocellular carcinoma patients
Group (number of unfavorable genotypes1)Death/TotalHR (95%CI)P value
In all patients
Group 1 (0)44/951 (ref)
Group 2 (1)47/971.08 (0.71-1.63)0.730
Group 3 (2)20/221.70a (1.30-2.22)< 0.001a
P for trend0.004a
In patients with age ≤ 55
Group 1 (0)18/471 (ref)
Group 2 (1)26/451.01 (0.52-1.95)0.975
Group 3 (2)14/162.00a (1.40-3.86)< 0.001a
P for trend0.003a
In patients with male gender
Group 1 (0)36/821 (ref)
Group 2 (1)34/750.97 (0.60-1.56)0.898
Group 3 (2)18/191.94a (1.45-2.59)< 0.001a
P for trend0.002a
In patients with cirrhosis
Group 1 (0)20/561 (ref)
Group 2 (1)24/561.29 (0.71-2.35)0.410
Group 3 (2)14/141.97a (1.39-2.79)< 0.001a
P for trend0.001a